Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Vanderstichele · SciRah

Researcher profile · Semantic Scholar

H. Vanderstichele

Share profile

H. Vanderstichele — researcher profile on SciRah

h-index: 67
Works: 215
Citations: 21K

Most-cited papers

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
S. Janelidze, H. Zetterberg, N. Mattsson, S. Palmqvist +7 more
2016Annals of Clinical and Translational Neurology404 citations Open access
Semantic Scholar
Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
P. Chatterjee, S. Pedrini, E. Stoops, Kathryn Goozee +11 more
2021Translational Psychiatry369 citations Open access
Semantic Scholar
Differences Between Early- and Late-Onset Alzheimer Disease and Stability During the Course of Disease
N. Andreasen, C. Hesse, P. Davidsson, L. Minthon +5 more
2017367 citations
Semantic Scholar
Blood Based Biomarkers in Alzheimer Disease: Current State of the Science and a Novel Collaborative Paradigm for Advancing from Discovery to Clinic
S. O'Bryant, M. Mielke, R. Rissman, S. Lista +18 more
2016Alzheimer's & Dementia279 citations Open access
Semantic Scholar
Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
C. Sutphen, Mateusz S. Jasielec, Aarti R. Shah, E. Macy +12 more
2015JAMA Neurology278 citations Open access
Semantic Scholar
Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
I. Verberk, Elisabeth H. Thijssen, Jannet Koelewijn, Kimberley Mauroo +12 more
2020Alzheimer's Research & Therapy233 citations Open access
Semantic Scholar
Machine learning for comprehensive forecasting of Alzheimer’s Disease progression
Charles K. Fisher, Aaron M. Smith, J. Walsh, Adam J. Simon +20 more
2018Scientific Reports195 citations Open access
Semantic Scholar
Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases
A. Lleó, E. Cavedo, L. Parnetti, H. Vanderstichele +16 more
2015Nature Reviews Neurology161 citations
Semantic Scholar
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease
A. Rembach, N. G. Faux, Andrew D. Watt, K. Pertile +22 more
2014Alzheimer's & Dementia148 citations
Semantic Scholar
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia
Alice Bernardelli, D. Chiasserini, Leonardo Biscetti, P. Eusebi +12 more
2017Alzheimer's Research & Therapy129 citations Open access
Semantic Scholar
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
J. Toledo, H. Zetterberg, A. V. Van Harten, L. Glodzik +28 more
2015Brain : a journal of neurology123 citations Open access
Semantic Scholar
CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation.
J. Kuhlmann, U. Andreasson, Josef Pannee, M. Bjerke +13 more
2017Clinica chimica acta; international journal of clinical chemistry122 citations
Semantic Scholar
Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology: How specific are the conformation-specific α-synuclein antibodies?
Senthil T. Kumar, Somanath Jagannath, Cindy François, H. Vanderstichele +2 more
2020bioRxiv121 citations Open access
Semantic Scholar
Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease
D. Galasko, Mei-Fang Xiao, De-Sheng Xu, D. Smirnov +7 more
2019Alzheimer's & Dementia119 citations Open access
Semantic Scholar
The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau
O. Hansson, R. Batrla, Britta Brix, Maria C. Carrillo +19 more
2021Alzheimer's & Dementia118 citations Open access
Semantic Scholar
The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review
O. Hansson, Alvydas Mikulskis, A. Fagan, C. Teunissen +13 more
2018Alzheimer's & Dementia109 citations Open access
Semantic Scholar
CSF A beta 42/A beta 40 and A beta 42/A beta 38 ratios: better diagnostic markers of Alzheimer disease
S. Janelidze, H. Zetterberg, N. Mattsson, S. Palmqvist +7 more
2016105 citations
Semantic Scholar
The Alzheimer’s Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans
Ju-Hee Kang, M. Korecka, Michał J. Figurski, Jon B. Toledo +15 more
2015Alzheimer's & Dementia102 citations Open access
Semantic Scholar
Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis
Steffi De Meyer, J. Schaeverbeke, I. Verberk, B. Gille +11 more
2020Alzheimer's Research & Therapy92 citations Open access
Semantic Scholar
Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays
Niccolò Candelise, M. Schmitz, Katrin Thüne, M. Cramm +7 more
2020Translational Neurodegeneration79 citations Open access
Semantic Scholar
Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale
S. Lehmann, C. Delaby, Guilaine Boursier, Cindy Catteau +9 more
2018Frontiers in Aging Neuroscience79 citations Open access
Semantic Scholar
Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes
H. Vanderstichele, S. Janelidze, Leentje Demeyer, E. Coart +5 more
2016Journal of Alzheimer's Disease70 citations Open access
Semantic Scholar
Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer’s disease
Elisabeth H. Thijssen, I. W. Verberk, Jeroen Vanbrabant, A. Koelewijn +6 more
2020Scientific Reports68 citations Open access
Semantic Scholar
How to handle adsorption of cerebrospinal fluid amyloid β (1–42) in laboratory practice? Identifying problematic handlings and resolving the issue by use of the Aβ42/Aβ40 ratio
E. Willemse, K. V. van Uffelen, Britta Brix, S. Engelborghs +2 more
2017Alzheimer's & Dementia67 citations Open access
Semantic Scholar
C-Reactive Protein, Plasma Amyloid-&bgr; Levels, and Their Interaction With Magnetic Resonance Imaging Markers
S. Hilal, M. Ikram, M. Verbeek, O. Franco +4 more
2018Stroke65 citations Open access
Semantic Scholar
A user's guide for α‐synuclein biomarker studies in biological fluids: Perianalytical considerations
B. Mollenhauer, R. Batrla, O. El-Agnaf, D. Galasko +13 more
2017Movement Disorders61 citations Open access
Semantic Scholar
Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements
M. Bjerke, U. Andreasson, J. Kuhlmann, E. Portelius +20 more
2016Clinical Chemistry and Laboratory Medicine56 citations
Semantic Scholar
First amyloid β1‐42 certified reference material for re‐calibrating commercial immunoassays
S. Boulo, J. Kuhlmann, U. Andreasson, Britta Brix +32 more
2020Alzheimer's & Dementia54 citations Open access
Semantic Scholar
Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin study
B. Mollenhauer, F. Bowman, D. Drake, Jimmy Duong +20 more
2018Journal of Neurochemistry50 citations Open access
Semantic Scholar
Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition
J. Schelle, Lisa M. Häsler, J. Göpfert, T. Joos +8 more
2017Alzheimer's & Dementia50 citations
Semantic Scholar
Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study
S. Hilal, S. Akoudad, C. M. van Duijn, W. Niessen +5 more
2017Journal of Alzheimer's Disease50 citations
Semantic Scholar
Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study
S. Hilal, F. Wolters, M. Verbeek, H. Vanderstichele +4 more
2018Alzheimer's Research & Therapy48 citations Open access
Semantic Scholar
Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team
S. Arneric, R. Batrla‐Utermann, L. Beckett, T. Bittner +20 more
2016Journal of Alzheimer's Disease48 citations Open access
Semantic Scholar
Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease
Katarzyna Adamczuk, J. Schaeverbeke, H. Vanderstichele, Johan Lilja +6 more
2015Alzheimer's Research & Therapy47 citations Open access
Semantic Scholar
Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer’s Disease
P. Chatterjee, Mitra Elmi, Kathryn Goozee, T. Shah +11 more
2019Journal of Alzheimer's Disease45 citations Open access
Semantic Scholar
CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease
F. Mouton-Liger, J. Dumurgier, Emmanuel Cognat, C. Hourrègue +7 more
2020Alzheimer's Research & Therapy38 citations Open access
Semantic Scholar
Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements
U. Andreasson, J. Kuhlmann, Josef Pannee, R. Umek +11 more
2018Clinical Chemistry and Laboratory Medicine37 citations Open access
Semantic Scholar
The global Alzheimer's Association round robin study on plasma amyloid β methods
Josef Pannee, L. Shaw, M. Korecka, T. Waligórska +31 more
2021Alzheimer's & Dementia36 citations Open access
Semantic Scholar
Relation of Odor Identification with Alzheimer’s Disease Markers in Cerebrospinal Fluid and Cognition
Babette L. R. Reijs, I. Ramakers, L. Elias-Sonnenschein, C. Teunissen +10 more
2017Journal of Alzheimer's Disease36 citations Open access
Semantic Scholar
Performance Evaluation of an Automated ELISA System for Alzheimer’s Disease Detection in Clinical Routine
D. Chiasserini, Leonardo Biscetti, L. Farotti, P. Eusebi +9 more
2016Journal of Alzheimer's Disease36 citations
Semantic Scholar
Memory Correlates of Alzheimer’s Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study
Babette L. R. Reijs, I. Ramakers, S. Köhler, C. Teunissen +12 more
2017Journal of Alzheimer's Disease32 citations Open access
Semantic Scholar
Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies
M. van de Beek, R. B. Mofrad, I. van Steenoven, H. Vanderstichele +4 more
2020Alzheimer's Research & Therapy30 citations Open access
Semantic Scholar
Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy
M. Schmitz, Anna Villar-Piqué, F. Llorens, K. Gmitterová +10 more
2018Molecular Neurobiology28 citations
Semantic Scholar
Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adults
Jun Yuan, S. Pedrini, R. Thota, J. Doecke +20 more
2023npj Aging26 citations Open access
Semantic Scholar
Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer’s Disease Pathology Between Three Independent Assay Platforms
J. Doecke, A. Rembach, V. Villemagne, S. Varghese +20 more
2017Journal of Alzheimer's Disease25 citations
Semantic Scholar
Ex vivo18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway
E. Portelius, N. Mattsson, Josef Pannee, H. Zetterberg +8 more
2017Molecular Neurodegeneration25 citations Open access
Semantic Scholar
Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs
S. Lerche, K. Brockmann, A. Pilotto, I. Wurster +12 more
2016Alzheimer's Research & Therapy25 citations Open access
Semantic Scholar
Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1–42)/Aβ(1–40)
H. Vanderstichele, Leentje Demeyer, S. Janelidze, E. Coart +5 more
2017Alzheimer's Research & Therapy24 citations Open access
Semantic Scholar
Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer’s Disease
E. Niemantsverdriet, Joery Goossens, H. Struyfs, Jean-Jacques Martin +4 more
2016Journal of Alzheimer's Disease24 citations Open access
Semantic Scholar
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
C. Cicognola, D. Chiasserini, P. Eusebi, U. Andreasson +4 more
2016Molecular Neurodegeneration23 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Stoops×24
Invite
E. Stoops — researcher profile on SciRah
K. Blennow×22
Invite
K. Blennow — researcher profile on SciRah
H. Zetterberg×21
Invite
H. Zetterberg — researcher profile on SciRah
C. Teunissen×12
Invite
C. Teunissen — researcher profile on SciRah

×8

Invite

O. Hansson — researcher profile on SciRah

Invite

M. Vandijck — researcher profile on SciRah

Invite

L. Shaw — researcher profile on SciRah

Invite

P. Lewczuk — researcher profile on SciRah

Invite

Britta Brix — researcher profile on SciRah

U. Andreasson×6

Invite

U. Andreasson — researcher profile on SciRah

Josef Pannee×6

Invite

Josef Pannee — researcher profile on SciRah

E. Portelius×6

Invite

E. Portelius — researcher profile on SciRah